Liu et al. reported that FoxP3 underexpression was closely related to a decreased overall survival (OS), and low FoxP3 expression was an independent risk factor for predicting OS prognosis of HCC patients (Liu et al. 2023). This evidence concerns the gene FOXP3 and hepatocellular carcinoma.